ILIMED
ActiveSummary
ILIMED has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.8m and a net result of €359,978. Equity is growing by ~19.9% per year across the filed fiscal years. Its solvency ranks better than 29% of 16718 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability78▼-3
Solvency61▼-39
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €120,000 at 30 days acceptable
Liquidity short (current ratio 0.2 against 4.06 in 2024; short-term debt: 60.2% and cash: 2.8% of total assets), and 64.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
35.8%
Return on assets
7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
7 d late
2023
68 d late
2022
59 d late
2021
123 d late
2020
31 d late
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 41 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€359,978▲ 65.9%
2024 · €216,960
Working capital
-€2.5m
2024 · €705,188
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€474,748▲ 565%€510,373▲ 7.5%€345,992▼ 32.2%€442,663▲ 27.9%€472,705▲ 6.8%
Net result€339,670above the sector's middle half▲ 744%€391,997above the sector's middle half▲ 15.4%€229,274above the sector's middle half▼ 41.5%€216,960above the sector's middle half▼ 5.4%€359,978above the sector's middle half▲ 65.9%
Equity€1.0mabove the sector's middle half▲ 50.6%€1.3mabove the sector's middle half▲ 32.2%€1.4mabove the sector's middle half▲ 4.3%€1.8mabove the sector's middle half▲ 29.8%€1.8mabove the sector's middle half▲ 1.4%
Total assets€1.3mabove the sector's middle half▲ 21.4%€2.4mabove the sector's middle half▲ 75.8%€2.1mabove the sector's middle half▼ 9.2%€2.3mabove the sector's middle half▲ 6.3%€5.1mabove the sector's middle half▲ 125%
Debt€321,650▼ 24.4%€1.0m▲ 214%€737,486▼ 27.1%€456,940▼ 38.0%€3.3m▲ 618%
Working capital€730,312▲ 81.8%€56,029▼ 92.3%€239,936▲ 328%€705,188▲ 194%-€2.5m
Solvency75.5%within the sector's middle half▲ 14.6pp56.8%within the sector's middle half▼ 18.7pp65.2%within the sector's middle half▲ 8.4pp79.6%within the sector's middle half▲ 14.4pp35.8%within the sector's middle half▼ 43.8pp
Staff (FTE)2.6within the sector's middle half▼ 3.7%4.7▲ 80.8%4▼ 14.9%5.1
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 7% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.1m
Fixed assets
€4.5m ▲ 237%
Current assets
€612,058 ▼ 34.6%
Equity and liabilities €5.1m
Equity
€1.8m ▲ 1.4%
Provisions
€6,000 =
Debt
€3.3m ▲ 618%
Debt's share of the balance-sheet total rises from 20.1% to 64.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€537,987▲
2024 · €515,301
Cash flow
€425,261▲
2024 · €289,598
Current ratio
0.20▼
2024 · 4.06
Debt to equity
1.79▲
2024 · 0.25
ROE
19.6%▲
2024 · 12.0%
ROA
7.0%▼
2024 · 9.5%
Interest coverage
55.10▲
2024 · 42.33
Debt ≤ 1 year
€3.1m▲
2024 · €230,309
Debt > 1 year
€50,916▼
2024 · €86,989
Income taxes
€109,377▼
2024 · €220,129
Staff costs
€96,597▼
2024 · €115,394
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €97,025 | €121,548 | €157,385 | €115,394 | €96,597 | ▼ 16.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €65,468 | €89,728 | €101,989 | €72,638 | €65,283 | ▼ 10.1% |
| Other operating charges640/8 | €13,905 | €51,901 | €14,406 | €14,662 | €20,239 | ▲ 38.0% |
| Gross operating margin9900 | €651,147 | €773,550 | €619,773 | €645,357 | €654,823 | ▲ 1.5% |
| Operating profit (loss)9901 | €474,748 | €510,373 | €345,992 | €442,663 | €472,705 | ▲ 6.8% |
| Financial income75/76B | €8,330 | €34,999 | €11,236 | €6,600 | €6,414 | ▼ 2.8% |
| Recurring financial income75 | €8,330 | €16,169 | €11,236 | €6,600 | €6,414 | ▼ 2.8% |
| Non-recurring financial income76B | - | €18,831 | - | - | - | - |
| Financial charges65/66B | €13,408 | €31,081 | €14,486 | €12,174 | €9,764 | ▼ 19.8% |
| Recurring financial charges65 | €13,408 | €16,833 | €14,486 | €12,174 | €9,764 | ▼ 19.8% |
| Non-recurring financial charges66B | - | €14,249 | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €469,670 | €514,291 | €342,741 | €437,089 | €469,355 | ▲ 7.4% |
| Income taxes67/77 | €130,000 | €122,294 | €113,467 | €220,129 | €109,377 | ▼ 50.3% |
| Profit (loss) for the period9904 | €339,670 | €391,997 | €229,274 | €216,960 | €359,978 | ▲ 65.9% |
| Profit (loss) for the period to be appropriated9905 | €339,670 | €391,997 | €229,274 | €216,960 | €359,978 | ▲ 65.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.3m | €2.4m | €2.1m | €2.3m | €5.1m | ▲ 125% |
| Fixed assets21/28 | €499,990 | €1.5m | €1.4m | €1.3m | €4.5m | ▲ 237% |
| Tangible fixed assets22/27 | €499,990 | €1.5m | €1.4m | €1.3m | €1.3m | ▼ 1.9% |
| Land and buildings22 | €357,444 | €1.4m | €1.3m | €1.3m | €1.3m | ▼ 0.8% |
| Plant, machinery and equipment23 | €91,996 | €87,046 | €44,964 | €33,443 | €18,714 | ▼ 44.0% |
| Furniture and vehicles24 | €50,550 | €20,441 | €6,145 | - | - | - |
| Financial fixed assets28 | - | - | - | - | €3.2m | - |
| Current assets29/58 | €838,301 | €870,710 | €737,455 | €935,497 | €612,058 | ▼ 34.6% |
| Amounts receivable after more than one year29 | - | - | - | €446,600 | €411,428 | ▼ 7.9% |
| Other amounts receivable291 | - | - | - | €446,600 | €411,428 | ▼ 7.9% |
| Amounts receivable within one year40/41 | €219,943 | €268,168 | €156,142 | €49 | €65 | ▲ 33.9% |
| Trade receivables40 | €19,052 | - | - | €49 | €65 | ▲ 33.9% |
| Other amounts receivable41 | €200,891 | €268,168 | €156,142 | - | - | - |
| Cash at bank and in hand54/58 | €525,925 | €602,541 | €581,314 | €486,383 | €141,930 | ▼ 70.8% |
| Deferred charges and accrued income490/1 | €92,433 | - | - | €2,465 | €58,635 | ▲ 2,279% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.3m | €2.4m | €2.1m | €2.3m | €5.1m | ▲ 125% |
| Equity10/15 | €1.0m | €1.3m | €1.4m | €1.8m | €1.8m | ▲ 1.4% |
| Contributions10/11 | €18,592 | €18,592 | €18,592 | €18,592 | €18,592 | = |
| Reserves13 | €952,378 | €1.3m | €1.3m | €1.7m | €1.4m | ▼ 19.4% |
| Non-distributable reserves130/1 | €1,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Reserves not available under the articles1311 | €1,859 | €1,859 | €1,859 | €1,859 | €1,859 | = |
| Tax-exempt reserves132 | €123 | €123 | €123 | €123 | €123 | = |
| Distributable reserves133 | €950,396 | €1.3m | €1.3m | €1.7m | €1.4m | ▼ 19.4% |
| Profit (loss) carried forward14 | €39,670 | €41,667 | €41,671 | €69,750 | €429,728 | ▲ 516% |
| Provisions and deferred taxes16 | €6,000 | €6,000 | €6,000 | €6,000 | €6,000 | = |
| Provisions for liabilities and charges160/5 | €6,000 | €6,000 | €6,000 | €6,000 | €6,000 | = |
| Pensions and similar obligations160 | €6,000 | €6,000 | €6,000 | €6,000 | €6,000 | = |
| Amounts payable17/49 | €321,650 | €1.0m | €737,486 | €456,940 | €3.3m | ▲ 618% |
| Amounts payable after more than one year17 | €187,288 | €154,073 | €121,348 | €86,989 | €50,916 | ▼ 41.5% |
| Financial debts170/4 | €187,288 | €154,073 | €121,348 | €86,989 | €50,916 | ▼ 41.5% |
| Amounts payable within one year42/48 | €107,989 | €814,681 | €497,520 | €230,309 | €3.1m | ▲ 1,238% |
| Current portion of amounts payable after more than one year42 | €37,875 | €33,216 | €32,725 | €34,358 | €36,074 | ▲ 5.0% |
| Trade debts44 | €23,292 | €647,788 | €398,228 | €155,311 | €26,052 | ▼ 83.2% |
| Suppliers440/4 | €23,292 | €647,788 | €398,228 | €155,311 | €26,052 | ▼ 83.2% |
| Taxes, remuneration and social security45 | €46,822 | €119,550 | €66,567 | €40,639 | €29,096 | ▼ 28.4% |
| Taxes450/3 | €30,000 | €96,607 | €46,421 | €21,884 | €11,027 | ▼ 49.6% |
| Remuneration and social security454/9 | €16,822 | €22,943 | €20,146 | €18,755 | €18,069 | ▼ 3.7% |
| Other amounts payable47/48 | - | €14,127 | - | - | €3.0m | - |
| Accrued charges and deferred income492/3 | €26,373 | €42,406 | €118,618 | €139,642 | €149,100 | ▲ 6.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €339,670 | €391,997 | €229,274 | €216,960 | €359,978 | ▲ 65.9% |
| + Depreciation and write-downs630 | €65,468 | €89,728 | €101,989 | €72,638 | €65,283 | ▼ 10.1% |
| Operating cash flow (approximation) | €405,138 | €481,725 | €331,263 | €289,598 | €425,261 | ▲ 46.8% |
| Investment in fixed assets (approximation) | - | -€1.1m | -€19,663 | -€9,360 | -€3.2m | ▼ 34,515% |
| Change in cash | - | €76,617 | -€21,228 | -€94,930 | -€344,454 | ▼ 263% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
07-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 7 days late
2024
31-12
Financial
Liquidity triplescurrent ratio 4.06
Current ratio from 1.48 to 4.06; short-term debt falls from €497,520 to €230,309.
07-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 68 days late
2023
28-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 59 days late
2022
31-12
Financial
Highest result since 2018net €391,997 ▲15.4%
Net result €391,997, the highest in the series.
01-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 123 days late
2021
31-12
Financial
Liquidity doublescurrent ratio 7.76
Current ratio from 3.27 to 7.76; short-term debt falls from €176,663 to €107,989.
31-12
Financial
Equity above €1mEq €1.0m ▲50.6%
4 profitable years in a row build equity to €1.0m.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
2020
31-12
Financial
Weakest financial yearnet €40,258 ▼88%
Net result drops to €40,258, the lowest in the series; recovery starts the following year.
31-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
Show earlier events
2019
31-12
Financial
Equity above €500,000Eq €630,712 ▲113%
2 profitable years in a row build equity to €630,712.
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
06-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
31-10
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 92 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2003
Ground area
86 m²
Building footprint
86 m²
Volume, LiDAR
801 m³
Parcel 21012A0064/00B003, Brussels · tallest building 12.0 m, ±3 floors. Linked by address, not a title deed.
8
companies at this address
See who is registered here
1 establishment unit
ILIMED
since 20032.281.470.385
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21012A0064/00B003 | Brussels | 86 m² | 1 · 86 m² | 12.0 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
VERVAEKE
BE 0442.544.781
Wervik · Eq €1,837,794
DEVREESE HENK ORTHODONTIE
BE 0894.376.721
Aalter · Eq €1,821,017
DENTIX
BE 0561.728.087
Antwerpen · Eq €1,818,239
TANDARTSPRAKTIJK VERLINDE
BE 0537.641.405
Koksijde · Eq €1,816,728
LYS DENTAL
BE 0644.757.911
Schaarbeek · Eq €1,813,739
Of 6,945 companies in sector 86230 we hold annual accounts for 4,296. 2,226 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded22-01-2002
Fiscal year end31-12
Activities, NACEBEL 2025
86230Dental practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0476717584
Also
9925:BE0476717584
Registered
04-12-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.